Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathways
Crossref DOI link: https://doi.org/10.1038/oncsis.2016.9
Published Online: 2016-03-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, X
Shi, B
Li, L
Xu, Z
Ge, Y
Shi, J
Liu, Y
Zheng, D
Text and Data Mining valid from 2016-03-07
Version of Record valid from 2016-03-07
Article History
Received: 22 August 2015
Revised: 6 December 2015
Accepted: 13 December 2015
First Online: 7 March 2016
Competing interests
: The authors declare no conflict of interest.